Anticancer activity of subfractions containing pure compounds of Chaga mushroom (Inonotus obliquus) extract in human cancer cells and in Balbc/c mice bearing Sarcoma-180 cells
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
The Chaga mushroom (Inonotus obliquus) has been used in folk medicine to treat cancers. However, limited information exists on the underlying anticancer effects of the major component of I. obliquus in vivo. We hypothesize that the pure compounds (3β-hydroxy-lanosta-8,24-dien-21-al,inotodiol and lanosterol, respectively) separated from I. obliquus would inhibit tumor growth in Balbc/c mice bearing Sarcoma-180 cells (S-180)in vivo and growth of human carcinoma cells in vitro. To test this hypothesis, the growth inhibition of each subfraction isolated from I. obliquus on human carcinoma cell lines (lung carcinoma A-549 cells, stomach adenocarcinoma AGS cells, breast adenocarcinoma MCF-7 cells, and cervical adenocarcinoma HeLa cells) was tested in vitro. Then, after S-180 implantation, the mice were fed a normal chow supplemented with 0, 0.1 or 0.2 mg of subfraction 1, 2 or 3 per mouse per day. All of the subfractions isolated from I. obliquus showed significant cytotoxic activity against the selected cancer cell lines in vitro. Subfraction 1 was more active than subfraction 2 and subfraction 3 against the A549, AGS and MCF-7cancer cell lines in vitro. In in vivo results, subfraction 1 isolated from I. obliquus at concentrations of 0.1 and 0.2 mg/mouse per day significantly decreased tumor volume by 23.96% and 33.71%, respectively, as compared with the control. Subfractions 2 and 3 also significantly inhibited tumor growth in mice bearing S-180 as compared with the control mouse tumor. Subfraction 1 isolated from I. obliquus showed greater inhibition of tumor growth than subfractions 2 and 3, which agrees well with the in vitro results. The results suggest that I. obliquus and its compounds in these subfractions isolated from I. obliquus could be used as natural anticancer ingredients in the food and/or pharmaceutical industry.
Abstract
The Chaga mushroom (Inonotus obliquus) has been used in folk medicine to treat cancers. However, limited information exists on the underlying anticancer effects of the major component of I. obliquus in vivo. We hypothesize that the pure compounds (3β-hydroxy-lanosta-8,24-dien-21-al,inotodiol and lanosterol, respectively) separated from I. obliquus would inhibit tumor growth in Balbc/c mice bearing Sarcoma-180 cells (S-180)in vivo and growth of human carcinoma cells in vitro. To test this hypothesis, the growth inhibition of each subfraction isolated from I. obliquus on human carcinoma cell lines (lung carcinoma A-549 cells, stomach adenocarcinoma AGS cells, breast adenocarcinoma MCF-7 cells, and cervical adenocarcinoma HeLa cells) was tested in vitro. Then, after S-180 implantation, the mice were fed a normal chow supplemented with 0, 0.1 or 0.2 mg of subfraction 1, 2 or 3 per mouse per day. All of the subfractions isolated from I. obliquus showed significant cytotoxic activity against the selected cancer cell lines in vitro. Subfraction 1 was more active than subfraction 2 and subfraction 3 against the A549, AGS and MCF-7cancer cell lines in vitro. In in vivo results, subfraction 1 isolated from I. obliquus at concentrations of 0.1 and 0.2 mg/mouse per day significantly decreased tumor volume by 23.96% and 33.71%, respectively, as compared with the control. Subfractions 2 and 3 also significantly inhibited tumor growth in mice bearing S-180 as compared with the control mouse tumor. Subfraction 1 isolated from I. obliquus showed greater inhibition of tumor growth than subfractions 2 and 3, which agrees well with the in vitro results. The results suggest that I. obliquus and its compounds in these subfractions isolated from I. obliquus could be used as natural anticancer ingredients in the food and/or pharmaceutical industry.
참고문헌 (20)
- Sporn MB, "Prevention of cancer in the next millennium: report of the chemoprevention working group to the American association for cancer research", Cancer res, 59, pp.4743~4758 (1999)
- Roland JF, "Calvacin: A new antitumor agent", Science, 132, pp.1897~ (1960)
- Gregory FJ, "Studies on antitumor substances produced by Basidiomycetes", Mycologia, 58, pp.80~90 (1966)
- Saar M, "Fungi in Khanty folk medicine", J Ethnopharmacol, 31, pp.175~179 (1991)
- 함승시, "차가버섯 분획물의 항돌연변이 활성 및 암세포 성장억제효과", 한국식품영양과학회지, 32(7), pp.1088~1094 (2003), 한국식품영양과학회
- 함승시, "차가버섯 분획물의 항산화활성 및 유전독성 억제효과", 한국식품영양과학회지, 32(7), pp.1071~1075 (2003), 한국식품영양과학회
- Kahlos K, "3β-Hydroxy-lanosta-8,24- dien-21-al, a new triterpene from Inontus obliquus", Planta Med, 50, pp.197~198 (1984)
- Ichmura T, "Inhibition of HIV-1 protease by water-soluble lignin-like substance from an edible mushroom Fuscoporia obliqua", Biosci Biotechnol Biochem, 62, pp.575~577 (1998)
- Nakata T, "Structure determination of inonotsuoxides A and B and in vivo anti-tumor promoting activity of inotodiol from the sclerotia of Inonotus obliquus", Bioorg Med Chem, 15, pp.257~264 (2007)
- Lee SH, "Antitumor activity of water extract of a mushroom, Inonotus obliquus, against HT-29 human colon cancer cells", Phytother Res, 23, pp.1784~1789 (2009)
- Ham SS, "Antimutagenic effects of subfractions of Chaga mushroom (Inonotus obliquus) extract", Mutat Res, 672, pp.55~59 (2009)
- Chung MJ, "Zinc-mediated gene expression offers protection against H2O2-induced cytotoxicity", Toxicol Appl Pharmacol (2005)
- 함영안, "잔대 추출물들의 항돌연변이 및 항종양 효과", 한국식품영양과학회지, 38(1), pp.25~31 (2009), 한국식품영양과학회
- Maeda N, "Inhibitory effects of preventive and curative orally administered spinach glycoglycerolipid fraction on the tumor growth of sarcoma and colon in mouse graft models", Food Chem, 112, pp.205~210 (2009)
- Oh HT, "Masou salmon (Oncorhynchus masou) ethanol extract decrease 3-hydroxy-3-methylglutaryl coenzyme A reductase expression in diet-induced obese mice", Nutr Res, 29, pp.123~129 (2009)
- Kahlos K, "Identification of some lanostane type triterpenes from Inonotus obliquus", Acta Pharmaceutica Fennica, 92, pp.220~222 (1983)
- Mizuno T, "Antitumor and hypoglycemic activities of polysaccharides from the Sclerotia and Mycelia of Inonotus obliquus (Pers: Fe.) Pll. (Aphyllophoromycetideae)", International Journal of Medicinal Mushrooms, 1, pp.201~316 (1999)
- Kahlos T, "Antitumor activity of some compounds and fractions from an n-hexene extract of Inonotus obliquus", Acta Pharmaceutica Fennica, 96, pp.33~40 (1987)
- Nomura M, "Inotodiol, a lanostane triterpenoid, from Inonotus obliquus inhibits cell proliferation through caspase-3-dependent apoptosis", Anticancer Res, 28, pp.2691~2696 (2008)
- Youn MJ, "Potential anticancer properties of the water extract of lnonotus obliquus by induction of apoptosis in melanoma B16-F10 cells", J Ethnopharmacol, 121, pp.221~228 (2009)